register

News & Trends - Pharmaceuticals

New PBS listings to bring hope for Australians living with kidney disease, cystic fibrosis and cancer

Health Industry Hub | February 3, 2020 |

There’s new hope for Australians living with chronic kidney disease, cystic fibrosis, and tumours of the midgut, thanks to new and amended medicines listings on the Pharmaceutical Benefits Scheme (PBS) from 1 February 2020.

The Morrison Government listed Pharmacor Cinacalcet on the PBS to help more patients with chronic kidney disease who are on dialysis.

In 2017, about 17,000 Australians lost their lives to chronic kidney disease. This disease accounts for about 1.8 million hospitalisations – or 16% of all hospitalisations in Australia. Approximately 3,700 patients are expected to benefit from this listing each year. Without subsidy, patients would pay over $700 per year for Pharmacor Cinacalcet.

Vertex Pharmaceuticals’ Symdeko was listed on the PBS on 1 December 2019 for the treatment of cystic fibrosis, and will now be extended to ensure all patients with at least one residual function mutation in the CFTR gene have access to this medicine.

The Government will also extend the PBS listing of Novartis’ Sandostatin to patients with non‑functional neuroendocrine tumours of the midgut. Without the PBS subsidy, approximately 460 patients would otherwise pay more than $23,500 per year for treatment.

Enhance corporate branding and boost thought leadership to attract and retain quality employees. Health Industry Hub is the only one-stop-hub connecting Australia’s Pharma, MedTech, and Biotech industry professionals. Learn about our unique and proven media solutions developed by industry for industry.

Register FREE to receive the latest news, innovations and insights from Health Industry Hub; the only one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals and its key stakeholders.


News & Trends - MedTech & Diagnostics

Parliament passes lung cancer legislation

Parliament passes lung cancer legislation

Health Industry Hub | May 17, 2024 |

MedTech & Diagnostics News: Lung cancer is the leading cause of cancer death and is responsible for almost one in […]

More


News & Trends - Pharmaceuticals

Senator Ruston criticises Budget's lack of 'real seamanship' in tackling pressing healthcare challenges

Senator Ruston criticises Budget’s lack of ‘real seamanship’ in tackling pressing healthcare challenges

Health Industry Hub | May 17, 2024 |

Pharma News: Senator Anne Ruston, Shadow Health Minister, was warmly welcomed at the Post-Budget event held in Parliament House yesterday […]

More


News & Trends - MedTech & Diagnostics

Baxter announces branding for spin-off kidney care business

Baxter announces branding for spin-off kidney care business

Health Industry Hub | May 17, 2024 |

MedTech & Diagnostics News: Baxter has unveiled the mission and logo for its forthcoming kidney care and acute therapies company, […]

More


ESG

Health and climate strategy: All talk, no budget

Health and climate strategy: All talk, no budget

Health Industry Hub | May 16, 2024 |

ESG: The Federal Budget has sparked disappointment among health professionals for its lack of attention to addressing the escalating impacts […]

More


This content is copyright protected. Please subscribe to gain access.